-
公开(公告)号：US07978018B2
公开(公告)日：2011-07-12
申请号：US12372164
申请日：2009-02-17
IPC分类号： H01P1/38
CPC分类号： H01P1/383
摘要： A non-reciprocal circuit device comprising a magnetic plate F1; center conductors L1, L2, and L3 that are mutually insulated and disposed so as to intersect on magnetic plate F1; a plane conductor P1 that is disposed facing the center conductors with magnetic plate F1 placed therebetween, the plane conductor being connected to first ends of all the center conductors; matching capacitors C1 to C3 that have first ends grounded electrically and second ends connected to second ends of the center conductors; first matching circuits that have first ends connected to the second ends of the center conductors and second ends that are input/output ports; and a second matching circuit that has a first end connected to or integrated with the plane conductor and a second end grounded electrically.
摘要翻译： 一种包括磁性板F1的不可逆电路装置; 中心导体L1，L2和L3相互绝缘并设置成与磁板F1相交; 平面导体P1，面对中心导体设置有放置在其间的磁性板F1，平面导体连接到所有中心导体的第一端; 匹配电容器C1至C3，其具有接地的第一端，第二端连接到中心导体的第二端; 第一匹配电路，其具有连接到作为输入/输出端口的中心导体和第二端的第二端的第一端; 以及第二匹配电路，其具有连接到所述平面导体或与所述平面导体一体化的第一端和被电接地的第二端。
-
22.发明申请THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-MET AUTOPHOSPHORYLATION INHIBITING POTENCY 审中-公开三烯衍生物衍生物或喹啉衍生物或喹唑啉衍生物，具有c-MET自动抑制抑制作用公开(公告)号：US20090270391A1
公开(公告)日：2009-10-29
申请号：US11910078
申请日：2006-03-28
申请人： Kazuo Kubo , Takayuki Furuta , Tatsushi Osawa , Atsushi Miwa
发明人： Kazuo Kubo , Takayuki Furuta , Tatsushi Osawa , Atsushi Miwa
IPC分类号： A61K31/5377 , C07D495/04 , A61K31/4365 , A61K31/4709 , C07D401/12 , C07D413/12 , A61P35/00
CPC分类号： C07D495/04 , C07D401/12 , C07D471/04
摘要： An objective of the present invention is to provide compounds having antitumor activity. According to the present invention, there is provided compounds represented by formula (I) and pharmaceutically acceptable salts thereof, and solvates thereof: wherein R1 represents H or a substitutable unsaturated five- or six-membered heterocyclic ring; R2 represents H; X represents CH or N; Z represents O or S; E is absent or represents halogen, alkyl, or alkoxy; J represents S or O; and T represents phenyl, an unsaturated five- or six-membered heterocyclic ring, an unsaturated nine- or ten-membered bicyclic carbocyclic ring or heterocyclic ring.
摘要翻译： 本发明的目的是提供具有抗肿瘤活性的化合物。 根据本发明，提供式（I）表示的化合物及其药学上可接受的盐及其溶剂合物：其中R1表示H或可取代的不饱和五元或六元杂环; R2表示H; X表示CH或N; Z表示O或S; E不存在或表示卤素，烷基或烷氧基; J表示S或O; 和T表示苯基，不饱和五元或六元杂环，不饱和九元或十元双环碳环或杂环。
-
23.发明申请公开(公告)号：US20060211717A1
公开(公告)日：2006-09-21
申请号：US11432407
申请日：2006-05-12
申请人： Teruyuki Sakai , Terufumi Senga , Takayuki Furuta , Atsushi Miwa
发明人： Teruyuki Sakai , Terufumi Senga , Takayuki Furuta , Atsushi Miwa
IPC分类号： A61K31/517 , C07D403/02
CPC分类号： C07D215/233 , A61K31/47 , A61K31/4709 , A61K31/496 , A61K31/505 , A61K31/517 , A61K31/5377 , C07D231/12 , C07D233/56 , C07D233/88 , C07D249/08 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12
摘要： There are provided compounds which can be used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy. The compounds are those represented by formula (I) or pharmacologically acceptable salts or solvates thereof: wherein R1 and R2 represent hydrogen, alkyl or the like; R3, R4, R5, and R6 represent hydrogen, halogen, alkyl, alkoxy or the like; R11 and R12 represent hydrogen, alkyl, alkylcarbonyl or the like; and A represents any one of formulae (i) to (x), provided that compounds wherein R3, R4, R5 and R6 represent hydrogen and A represents group (v) wherein u is 0 (zero) and R19 represents phenyl optionally substituted by halogen, alkyl, or alkoxy are excluded.
摘要翻译： 提供的化合物可用于治疗由PDGF受体的自磷酸化介导的疾病，特别是可抑制新内膜形成肥大的化合物。 化合物是由式（I）表示的化合物或其药学上可接受的盐或溶剂化物：其中R 1和R 2代表氢，烷基等; R 3，R 4，R 5和R 6代表氢，卤素，烷基，烷氧基或 喜欢; R 11和R 12代表氢，烷基，烷基羰基等; 并且A表示式（i）至（x）中的任何一个，条件是其中R 3，R 4，R 5和R 5的化合物 代表氢，A代表其中u为0（零）且R 19表示任选被卤素，烷基或烷氧基取代的苯基的基团（ⅴ）。
-
公开(公告)号：US08970319B2
公开(公告)日：2015-03-03
申请号：US13337683
申请日：2011-12-27
CPC分类号： H03H7/38 , H01P1/2039 , H03H7/46 , H03H2007/386
摘要： A first line stub SB1 and one end of each of two switches SW1 and SW2 are connected to a transmission line 11L at spacings L1, L2 and L3 in order from the input end of the transmission line 11L, the other ends of the two switches are connected to a second line stub SB2, the first and second line stubs have an open end or short-circuit end, and matching at any of four frequency bands can be selected by combining on and off of the two switches SW1 and SW2.
摘要翻译： 两条开关SW1和SW2的第一线短截线SB1和一端分别以传输线11L的输入端依次连接到间隔L1，L2和L3的传输线11L，两个开关的另一端分别为 连接到第二线段SB2，第一和第二线短截线具有开路端或短路端，并且可以通过组合两个开关SW1和SW2的导通和关断来选择四个频带中的任一个的匹配。
-
公开(公告)号：US07821351B2
公开(公告)日：2010-10-26
申请号：US11846721
申请日：2007-08-29
IPC分类号： H01P1/36
CPC分类号： H01P1/387
摘要： An irreversible circuit element is configured by including a magnetic substance, a plurality of central conductors L1 to L3, one ends of which are connected to different input/output ports, arranged on the magnetic substance so as to intersect each other while being insulated from each other, a first conductor P1 connected to the other ends of all the central conductors L1 to L3, a second conductor, a plurality of matching capacitors (each configured by C1 to C3) connecting the one end of the central conductors L1 to L3 and the second conductor and a variable matching mechanism V1, one end of which is connected or integrated with the second conductor, capable of changing reactance between the one end and the other end thereof.
摘要翻译： 不可逆电路元件通过包括磁性物质，多个中心导体L1至L3（其一端连接到不同的输入/输出端口）而配置在磁性物质上，以便彼此相交，同时与每个 另一方面，连接到所有中心导体L1至L3的另一端的第一导体P1，连接中心导体L1至L3的一端的多个匹配电容器（由C1至C3组成的多个匹配电容器）和第二导体 第二导体和可变匹配机构V1，其一端与第二导体连接或集成，能够改变其一端与另一端之间的电抗。
-
公开(公告)号：US20080309426A1
公开(公告)日：2008-12-18
申请号：US11846721
申请日：2007-08-29
IPC分类号： H01P1/36
CPC分类号： H01P1/387
摘要： An irreversible circuit element is configured by including a magnetic substance, a plurality of central conductors L1 to L3, one ends of which are connected to different input/output ports, arranged on the magnetic substance so as to intersect each other while being insulated from each other, a first conductor P1 connected to the other ends of all the central conductors L1 to L3, a second conductor, a plurality of matching capacitors (each configured by C1 to C3) connecting the one end of the central conductors L1 to L3 and the second conductor and a variable matching mechanism V1, one end of which is connected or integrated with the second conductor, capable of changing reactance between the one end and the other end thereof.
摘要翻译： 不可逆电路元件通过包括磁性物质，多个中心导体L1至L3（其一端连接到不同的输入/输出端口）而配置在磁性物质上，以便彼此相交，同时与每个 另一方面，连接到所有中心导体L1至L3的另一端的第一导体P1，连接中心导体L1至L3的一端的多个匹配电容器（由C1至C3组成的多个匹配电容器）和第二导体 第二导体和可变匹配机构V1，其一端与第二导体连接或集成，能够改变其一端与另一端之间的电抗。
-
公开(公告)号：US20140038941A1
公开(公告)日：2014-02-06
申请号：US13983248
申请日：2012-02-01
申请人： Takashi Sawada , Tomohiro Danjo , Keiichi Motosawa , Takayuki Furuta , Maki Ichioka , Masamori Sugawara , Noriaki Uesaka
发明人： Takashi Sawada , Tomohiro Danjo , Keiichi Motosawa , Takayuki Furuta , Maki Ichioka , Masamori Sugawara , Noriaki Uesaka
IPC分类号： C07D471/04 , C07D519/00 , C07D487/04
CPC分类号： C07D471/04 , A61K31/4184 , A61K31/42 , A61K31/4355 , A61K31/4439 , A61K31/4525 , A61K31/497 , A61K31/519 , C07D487/04 , C07D519/00
摘要： A ring-fused heterocyclic derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof having a T-type calcium channel regulatory effect and useful as a pruritus therapeutic and/or preventive agent, and the like are provided. In the general formula (I), R1 represents optionally substituted lower alkyl, and the like; R2 represents an optionally substituted cycloalkyl, and the like; Q represents a hydrogen atom, and the like; R3 represents —C(═O)NR8R9 (wherein R8 and R9 may be the same or different, and each represents a hydrogen atom, and the like), and the like; L1 represents —CR11AR11B— (wherein R11A and R11B may be the same or different, and each represents a hydrogen atom, and the like), and the like; and W1 and W2 may be the same or different, and each represents C—R12 (wherein R12 represents a hydrogen atom, and the like), and the like.
摘要翻译： 提供由具有T型钙通道调节作用并可用作瘙痒治疗和/或预防剂的由以下通式（I）表示的环稠合杂环衍生物或其药学上可接受的盐。 在通式（I）中，R 1表示任选取代的低级烷基等; R2表示任选取代的环烷基等; Q表示氢原子等; R 3表示-C（= O）NR 8 R 9（其中R 8和R 9可以相同或不同，各自表示氢原子等）等。 L1表示-CR11AR11B-（其中R11A和R11B可以相同或不同，各自表示氢原子等）等。 并且W1和W2可以相同或不同，并且各自表示C-R12（其中R12表示氢原子等）等。
-
公开(公告)号：US20130225581A1
公开(公告)日：2013-08-29
申请号：US13810568
申请日：2011-07-15
IPC分类号： C07D495/04 , C07D401/14 , C07D413/14 , C07D401/12
CPC分类号： C07D495/04 , C07D401/12 , C07D401/14 , C07D413/14 , C07D417/14
摘要： The present invention provides a nitrogen-containing aromatic heterocyclic derivative represented by formula (I): [wherein W represents CR3 (wherein R3 represents a hydrogen atom or the like) or the like, R4 represents a hydrogen atom or the like, R5 represents a hydrogen atom or the like, R9 represents substituted imidazolyl, R12 and R13 may be the same or different, each represent a hydrogen atom or the like, R22 and R23 may be the same or different, each represent a hydrogen atom or the like, R24 represents a hydrogen atom or the like, Y represents C—R25 (wherein R25 represents a hydrogen atom or the like) or the like] or a pharmaceutically acceptable salt thereof and a FGFR inhibitor comprising, as an active ingredient, the nitrogen-containing aromatic heterocyclic derivative or the pharmaceutically acceptable salt thereof, or the like.
摘要翻译： 本发明提供式（I）表示的含氮芳香族杂环衍生物：[式中，W表示CR 3（式中，R 3表示氢原子等）等，R 4表示氢原子等，R 5表示 氢原子等，R 9表示取代的咪唑基，R 12和R 13可以相同或不同，各自表示氢原子等，R 22和R 23可以相同或不同，分别表示氢原子等，R 24 表示氢原子等，Y表示C-R25（其中R25表示氢原子等）等或其药学上可接受的盐和FGFR抑制剂，作为活性成分，含氮芳香族 杂环衍生物或其药学上可接受的盐等。
-
公开(公告)号：US20130141160A1
公开(公告)日：2013-06-06
申请号：US13816519
申请日：2012-02-13
IPC分类号： H03F1/32
CPC分类号： H03F1/3247 , H03F1/3241 , H03F3/189 , H03F3/24 , H04B2001/0425 , H04L27/368
摘要： A PAPR observation unit that measures PAPR in a distributed output of an input signal and PAPR in a combined output of a linear transmission path and a third order distortion generation path, a distortion observation unit that observes distortion in the output of a power amplifier, and a controller are provided, where the controller includes a third order out-of-band distortion compensation coefficient control unit that adjusts coefficients corresponding to an outside of an input signal band among frequency characteristic compensator coefficients on the basis of distortion observed by the distortion observation unit and a third order in-band distortion coefficient control unit that adjusts coefficients corresponding to an inside of the input signal band among frequency characteristic compensator coefficients on the basis of the observed PAPR.
摘要翻译： PAPR观测单元，其测量输入信号的分布式输出中的PAPR和在线性传输路径和三阶失真产生路径的组合输出中的PAPR，观察功率放大器的输出中的失真的失真观测单元，以及 提供一种控制器，其中控制器包括三阶带外失真补偿系数控制单元，其基于由失真观测单元观测到的失真来调整频率特性补偿器系数中与输入信号频带外部相对应的系数 以及第三级带内失真系数控制单元，其基于观察到的PAPR来调整与频率特性补偿器系数中的输入信号频带的内部对应的系数。
-
公开(公告)号：US20120176205A1
公开(公告)日：2012-07-12
申请号：US13337683
申请日：2011-12-27
IPC分类号： H03H7/38
CPC分类号： H03H7/38 , H01P1/2039 , H03H7/46 , H03H2007/386
摘要： A first line stub SB1 and one end of each of two switches SW1 and SW2 are connected to a transmission line 11L at spacings L1, L2 and L3 in order from the input end of the transmission line 11 L, the other ends of the two switches are connected to a second line stub SB2, the first and second line stubs have an open end or short-circuit end, and matching at any of four frequency bands can be selected by combining on and off of the two switches SW1 and SW2.
摘要翻译： 两条开关SW1和SW2的第一线短截线SB1和一端分别从传输线路11L的输入端依次连接到间隔L1，L2和L3的传输线11L，两个开关的另一端 连接到第二线短截线SB2，第一和第二线段具有开路端或短路端，并且可以通过组合两个开关SW1和SW2的导通和关断来选择四个频带中的任何一个的匹配。
-
-
-
-
-
-
-
-
-
搜索结果
31 条记录 (耗时 0.03 秒)